Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Ramipril, Atorvastatin, and Amlodipine
NCT04262765Phase 1Completed
- Sponsor
- Midas Pharma
- Start
- Feb 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ramipril, amlodipine and atorvastatin in hypertension (HTN) and hypercholesterolemia, sponsored by Midas Pharma. Primary endpoints: Maximum Plasma Concentration at steady state and Area under the Plasma concentration curve. Started Feb 2019; status: completed.
02
Drugs
ramiprilamlodipineatorvastatin
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT04262765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04262765.